Genome BC

The two projects aim to use genomics to prevent the spread of drug-resistant bacteria and expand the use of genomic testing in cancer, respectively.

The project aims to developa system to automate the coring of tumor samples based on identified targets for DNA and RNA extraction.

Despite highly effective HCV drugs, testing for resistance mutations is important to prevent the spread of resistant strains and to tailor treatment.

The consortium is collecting data from different omics streams for a cohort of individuals with autism spectrum disorders with the long-term goal of improving treatment.

The partners are planning a joint research center at Providence Health Care's St. Paul's Hospital in Vancouver and a center of excellence in China.

The partnership is part of a broader agreement between Genome BC and Genomics England to share data and tools around cancer and rare and infectious diseases.

The team will employ reverse vaccinology coupled with high-throughput genomics approaches, such as RNA-seq, to deliver the new vaccines within four years.

The effort aims to revitalize the commercial fishery for Coho salmon, and is part of a broader investment by the Canadian government into genomics research.

The partners will work together on the diagnosis and treatment of cancer and rare and infectious diseases.

Genome BC plans to use the funding to develop genomic tools that natural resource companies can use to address their needs.

Pages

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.